MicroPort® Invited Chinese Experts to Attend the Pakistan Cardiology Academic Conference for the First Time

Lahore, Pakistan -- recently, the 45th Pakistan Cardiology Academic Conference was held in Lahore, Pakistan. The conference was hosted by Pakistan Cardiology Association and Punjab Institute of Cardiology. This is the largest academic event of Cardiology in Pakistan, attracting nearly 2,000 people in the industry to participate. Invited by Shanghai MicroPort Medical (Group) Co., Ltd. ("MicroPort®"), Professor Chen Shaoliang, a famous cardiology interventional expert and vice president of Nanjing First Hospital, attended the conference. This was the first time that Chinese experts attended Pakistan Cardiology Academic Conference.
As the first participated Chinese expert, Professor Chen completed one surgery for the case of LAD-D1 bifurcation lesion in Punjab Institute of Cardiology together with the local doctors. For Bifurcation lesions in coronary artery bifurcation, the previous operational success rate was very low, and the long-term result of treatment was not very well. It is always challenging worldwide.
The operation applied the style of DK crush, which was invented by Professor Chen, and implanted 3 pieces of Firebird2™ Rapamycin-Eluting Coronary CoCr Stent System. The postoperative intravascular ultrasound (IVUS) result showed that the operation was successful. Professor Chen introduced the application methods for DK crush technique in complex bifurcation lesions to the Pakistani doctors. Such technique was praised with the advanced technology.
Subsequently, Professor Chen made a speech on the topic of applying double bracket technology for the treatment of bifurcation lesions. Based on his many years' experience of clinical treatment and research, he presented this unique treatment method. In addition, with the local doctors, he shared the clinical trial of the Firehawk® Rapamycin Target Eluting Coronary Stent System ("Firehawk®"), which was independent researched and developed by MicroPort®. The clinical trials results prove that the Firehawk® is safe and effective. The wonderful speech of Professor Chen enabled local doctors to have new understanding of complex bifurcation lesion treatment method, and to also have full confidence in and high expectations on the industry's first target eluting stent of MicroPort®.
In the exchange, Professor Chen also presented his unique view on how to promote the cooperation for the clinical research of complex diseases and primary doctors training. MicroPort® invitation of Professor Chen to Pakistan for academic exchanges laid a solid foundation for the friendly cooperation between China and Pakistan in the field of interventional, effectively enhanced the academic exchanges between Chinese and Pakistani doctors, and will continue to promote the follow-up deeper cooperation in the field of cardiac intervention between two countries.